<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Bcr-Abl oncogene causes human <z:e sem="disease" ids="C0856536" disease_type="Neoplastic Process" abbrv="">Philadelphia chromosome-positive</z:e> (Ph(+)) <z:hpo ids='HP_0001909'>leukemias</z:hpo>, including B-cell <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>) and <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) with <z:hpo ids='HP_0011010'>chronic</z:hpo> phase (<z:mp ids='MP_0005481'>CML</z:mp>-CP) to <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> (<z:mp ids='MP_0005481'>CML</z:mp>-BC) </plain></SENT>
<SENT sid="1" pm="."><plain>Previous studies have demonstrated that Src family kinases are required for the induction of <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>, but not for <z:mp ids='MP_0005481'>CML</z:mp>, which is induced by Bcr-Abl in mice </plain></SENT>
<SENT sid="2" pm="."><plain>In contrast, it has been reported that Fyn is up-regulated in human <z:mp ids='MP_0005481'>CML</z:mp>-BC compared with <z:mp ids='MP_0005481'>CML</z:mp>-CP, implicating Fyn in the <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> transition </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we aimed to delineate the exact role of Fyn in the induction/progression of Ph(+) <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>We found that Fyn is expressed in mouse hematopoietic cells at varying stages of development, including c-kit(+)Sca-1(+)Lin(-) cells </plain></SENT>
<SENT sid="5" pm="."><plain>Notably, Fyn is highly expressed in some of human <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, but not in human Ph(+) <z:hpo ids='HP_0001909'>leukemias</z:hpo> including <z:mp ids='MP_0005481'>CML</z:mp>-BC </plain></SENT>
<SENT sid="6" pm="."><plain>In mouse bone marrow transplantation models, mice transplanted with <z:mp ids='MP_0002169'>wild-type</z:mp> or Fyn-deficient bone marrow cells transduced with Bcr-Abl showed no differences in the development of <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> or <z:mp ids='MP_0005481'>CML</z:mp>-like diseases </plain></SENT>
<SENT sid="7" pm="."><plain>Similarly, Fyn deficiency failed to impact the development of myeloid <z:mp ids='MP_0005481'>CML</z:mp>-BC induced by Bcr-Abl and Hes1 </plain></SENT>
<SENT sid="8" pm="."><plain>Elevated expression of Fyn was not found in mouse samples of Bcr-Abl-mediated <z:mp ids='MP_0005481'>CML</z:mp>- and <z:mp ids='MP_0005481'>CML</z:mp>-BC-like diseases </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, Fyn is not required for the pathogenesis of Bcr-Abl-mediated <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
</text></document>